4Filing Date: Aug 18, 2026
J&J (JNJ)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000200406-26-000175
Total Value$5.69M
Trades3
Insiders1
Transaction Details
Taubert Jennifer L
EVP, WWC. Innovative Medicine·Direct
Exercise · Acquire
Common Stock
Shares+15.00K
Price$115.67
Total Value$1.74M
Shares Owned After209.45K
Transaction DateAug 17, 2026
Taubert Jennifer L
EVP, WWC. Innovative Medicine·Direct
Exercise · Dispose
Employee Stock Options (Right to Buy)Derivative
Shares-15.00K
Price$0.00
Total Value$0
Shares Owned After28.71K
Transaction DateAug 17, 2026
ExpiresFeb 13, 2027
Footnotes ▸
Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Taubert Jennifer L
EVP, WWC. Innovative Medicine·Direct
Sell · Dispose
Common Stock
Shares-15.00K
Price$263.36
Total Value$3.95M
Shares Owned After194.45K
Transaction DateAug 17, 2026
Footnotes ▸
This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Post-Transaction Holdings
Taubert Jennifer L · EVP, WWC. Innovative Medicine
| Security | Shares | Change |
|---|---|---|
| Common Stock | 209.45K | - |
| Employee Stock Options (Right to Buy) | 28.71K | -15.00K (-34.32%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-08-17
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
--- Reporting Owner ---
Name: Taubert Jennifer L
CIK: 0001745938
Role: Officer (EVP, WWC. Innovative Medicine)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-08-17 | Code: M (Exercise of derivative)
Shares: +15,000 | Price: $115.67
Total Value: $1,735,050.00
Shares Owned After: 209,451.001 | Ownership: D (Direct)
[Transaction #2]
Security: Common Stock
Date: 2026-08-17 | Code: S (Open market sale)
Shares: -15,000 | Price: $263.36
Total Value: $3,950,400.00
Shares Owned After: 194,451.001 | Ownership: D (Direct)
Footnotes:
[F1] This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
--- Derivative Transactions ---
[Transaction #1]
Security: Employee Stock Options (Right to Buy)
Date: 2026-08-17 | Code: M (Exercise of derivative)
Shares: -15,000 | Price: $0.00
Exercisable: N/A | Expires: 2027-02-13
Shares Owned After: 28,712 | Ownership: D (Direct)
Footnotes:
[F2] Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
--- Footnotes (Complete Index) ---
F1: This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
--- Signature ---
/s/ /s/ Joleen Morgan, as attorney-in-fact for Jennifer Taubert (2026-08-18)